[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20003141D0 - Farmasøytiske blandinger - Google Patents

Farmasøytiske blandinger

Info

Publication number
NO20003141D0
NO20003141D0 NO20003141A NO20003141A NO20003141D0 NO 20003141 D0 NO20003141 D0 NO 20003141D0 NO 20003141 A NO20003141 A NO 20003141A NO 20003141 A NO20003141 A NO 20003141A NO 20003141 D0 NO20003141 D0 NO 20003141D0
Authority
NO
Norway
Prior art keywords
pharmaceutical mixtures
pharmaceutical
mixtures
Prior art date
Application number
NO20003141A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003141L (no
Inventor
Susan Jane Corvari
Joseph Richard Creekmore
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20003141L publication Critical patent/NO20003141L/no
Publication of NO20003141D0 publication Critical patent/NO20003141D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20003141A 1997-12-18 2000-06-16 Farmasøytiske blandinger NO20003141D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726735.5A GB9726735D0 (en) 1997-12-18 1997-12-18 Pharmaceutical compositions
PCT/GB1998/003765 WO1999032082A2 (en) 1997-12-18 1998-12-15 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO20003141L NO20003141L (no) 2000-06-16
NO20003141D0 true NO20003141D0 (no) 2000-06-16

Family

ID=10823809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003141A NO20003141D0 (no) 1997-12-18 2000-06-16 Farmasøytiske blandinger

Country Status (30)

Country Link
US (1) US6399104B1 (uk)
EP (1) EP1041966B1 (uk)
JP (1) JP2001526206A (uk)
KR (1) KR20010033206A (uk)
CN (1) CN1282244A (uk)
AR (1) AR017884A1 (uk)
AT (1) ATE243999T1 (uk)
AU (1) AU744326C (uk)
BR (1) BR9813666A (uk)
CA (1) CA2313163A1 (uk)
DE (1) DE69816124T2 (uk)
DK (1) DK1041966T3 (uk)
EE (1) EE04260B1 (uk)
ES (1) ES2202915T3 (uk)
GB (1) GB9726735D0 (uk)
HU (1) HUP0004669A3 (uk)
ID (1) ID25857A (uk)
IL (1) IL136501A0 (uk)
IN (1) IN191311B (uk)
MY (1) MY133096A (uk)
NO (1) NO20003141D0 (uk)
NZ (1) NZ504566A (uk)
PL (1) PL341736A1 (uk)
PT (1) PT1041966E (uk)
RU (1) RU2205006C2 (uk)
SK (1) SK9402000A3 (uk)
TR (1) TR200001713T2 (uk)
UA (1) UA62991C2 (uk)
WO (1) WO1999032082A2 (uk)
ZA (1) ZA9811532B (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO319624B1 (no) 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
DE602007013567D1 (de) * 2006-08-16 2011-05-12 Novartis Ag Verfahren zur herstellung fester dispersionen von midostaurin
KR20090122489A (ko) * 2007-03-26 2009-11-30 데이코쿠 세이야쿠 가부시키가이샤 결장-특이적 전달을 위한 경구적 약제학적 제제
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US11872210B2 (en) 2017-01-30 2024-01-16 Western New England University Thiol isomerases inhibitors and use thereof
CN107714694A (zh) * 2017-11-01 2018-02-23 天津国际生物医药联合研究院 扎鲁司特在抗结核分枝杆菌感染中的应用
JP2024521736A (ja) 2021-05-19 2024-06-04 クエルシス ファーマ エージー 筋萎縮性側索硬化症の治療に使用するためのケルセチン含有組成物
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
DK1041966T3 (da) 2003-10-06
DE69816124D1 (de) 2003-08-07
SK9402000A3 (en) 2001-01-18
HUP0004669A1 (hu) 2001-08-28
ID25857A (id) 2000-11-09
PT1041966E (pt) 2003-11-28
CN1282244A (zh) 2001-01-31
KR20010033206A (ko) 2001-04-25
JP2001526206A (ja) 2001-12-18
EP1041966A2 (en) 2000-10-11
AU744326C (en) 2002-11-07
HUP0004669A3 (en) 2005-03-29
EE04260B1 (et) 2004-04-15
BR9813666A (pt) 2000-10-10
NO20003141L (no) 2000-06-16
NZ504566A (en) 2002-10-25
IL136501A0 (en) 2001-06-14
UA62991C2 (en) 2004-01-15
AU744326B2 (en) 2002-02-21
GB9726735D0 (en) 1998-02-18
AU1571199A (en) 1999-07-12
EP1041966B1 (en) 2003-07-02
US6399104B1 (en) 2002-06-04
RU2205006C2 (ru) 2003-05-27
WO1999032082A3 (en) 1999-09-16
PL341736A1 (en) 2001-05-07
ATE243999T1 (de) 2003-07-15
AR017884A1 (es) 2001-10-24
WO1999032082A2 (en) 1999-07-01
IN191311B (uk) 2003-11-22
CA2313163A1 (en) 1999-07-01
ES2202915T3 (es) 2004-04-01
MY133096A (en) 2007-10-31
EE200000330A (et) 2001-08-15
ZA9811532B (en) 1999-06-18
TR200001713T2 (tr) 2000-10-23
DE69816124T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
NO20001776D0 (no) Medikamenter
NO985337D0 (no) Tetrahydrolipstatin-holdige blandinger
ID24654A (id) Formulasi farmasi omeprazola
DK0783302T3 (da) Lægemidler
ID24176A (id) Bahan pembantu sementasi
DE69719823D1 (de) Blisterverpackung
NO980546D0 (no) Farmasöytiske midler
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
DE69820407D1 (de) Blisterpackung
NO985539D0 (no) Farmas°ytiske blandinger
DK1017392T3 (da) Lægemiddel
IS5331A (is) Ný lyfjablanda
ID27150A (id) Sediaan levotiroksin bahan farmasi
IS2150B (is) Statín-karboxýalkýleter-blöndur
NO994619D0 (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
DE69926012D1 (de) Arzneizubereitungen
DE69906934D1 (de) Arzneizubereitungen
ATE238786T1 (de) Anti-first-pass-effect-substanzen
ID23531A (id) Komposisi farmasi
ID21180A (id) Senyawa-senyawa farmasi
FR2772264B1 (fr) Pilulier
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
BR1100755A (pt) composição farmacêutica
UA25523A (uk) Лікувальhий препарат гірчичhик

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application